Plain‑language drug resistant epilepsy research: who benefits from surgery, devices, diets, and emerging treatments.
Researchers studied the use of vigabatrin (VGB) as a preventive treatment for infants with tuberous sclerosis complex (TSC), a condition that often leads to early-onset epilepsy.
This study looked at a specific genetic cause of focal epilepsy called DEPDC5 variants, which are often linked to brain abnormalities.
Researchers studied the effects of Ivermectin (IVM) on patients with drug-resistant epilepsy, which means their seizures are hard to control even with multiple medications.
Researchers studied how deep brain stimulation (DBS) and responsive neurostimulation (RNS) can help people with drug-resistant epilepsy (DRE), which is epilepsy that doesn’t respond to medications.
This study looked at a group of Japanese patients with specific genetic changes known as DHDDS variants, which are linked to severe epilepsy and movement disorders.
This study looked at how two different surgical methods for treating drug-resistant mesial temporal lobe epilepsy affect thinking skills, particularly memory and naming abilities.
Researchers studied the use of a medication called perampanel, which is already approved for treating seizures in epilepsy, to see if it could help people with severe tremors.
This study looked at Tuberous Sclerosis Complex (TSC), a rare genetic disorder, in Greece.
This study looked at the effects of resective surgery on children with drug-resistant epilepsy related to tuberous sclerosis complex (TSC).